MedeAnalytics to spotlight Healthcare Performance Innovation at HIMSS 2026 with dual Speaking Sessions. Focus on "how-to" operationalize intelligence to drive ROI that improves performance RICHARDSON, Texas-(BUSINESS WIRE)-#HIMSS-MedeAnalytics, the healthcare performance improvement company, today announced its participation at the HIMSS Global Health Conference & Exhibition, taking place March 9-12, 2026 in Las Vegas. MedeAnalytics will deliver two featured speaking sessions focused on how to scale health data transformation to drive AI-powered enterprise healthcare analytics, and how AI-driven workflow tools can operationalize insights to improve cost, MLR, and quality outcomes that unleash measurable performance improvement. HIMSS26 Speaking Sessions both featuring David "Fig" Figueredo, Chief Innovation Officer at MedeAnalytics Mastering Healthcare ROI: From Basic Analytics to AI-Powered Precision Targeting Tuesday, March 10, 2026 | 10:15-11:15 AM PT | Level 3, Lido 3101A Learning Objective: Learn how to prove ROI using various methodologies, balancing analytical rigor with scalability that drive clear, defensible outcomes, and smarter investment decisions. From Days to Hours: Scaling Employer Reporting and Data Processing at a Multi-State Health Plan Wednesday, March 11, 2026 | 3:00-3:20 PM PT | Snowflake Booth 5247 Learning Objective: See how leading organizations are accelerating large-scale data processing to drive insights, efficiencies, and scalability faster - resulting in dramatically faster time to value. From Data to Intelligence to Accountable Action Healthcare's problem is not a lack of data. It is deriving the most impactful insights and turning them into sustained financial improvement. At HIMSS26, MedeAnalytics will highlight its evolution into a differentiated market leader uniquely combining an enterprise health data management platform with predictive healthcare intelligence, integrated workflow, and automation capabilities that operationalize execution, all powered by AI - helping customers close the persistent insights-to-action gap that continues to constrain healthcare performance. Healthcare organizations have invested heavily in analytics and AI, yet the ability to translate insights into measurable financial and clinical outcomes remains elusive. MedeAnalytics addresses this challenge by unifying clinical, claims, financial, and SDOH data into a single, trusted AI-native foundation and embedding capabilities that catalyze action directly into operational workflows. "MedeAnalytics was built on the market feedback that insights alone are no longer enough," said Steve Grieco, Chief Executive Officer of MedeAnalytics. "At HIMSS, we're showcasing how our differentiated combination of a modern healthcare data management platform, powering enterprise predictive analytics, and integrated workflow and automation tools, all powered by AI, operationalize the changes customers need to improve performance." Healthcare leaders attending HIMSS26 are invited to connect with MedeAnalytics executives onsite to explore how modern healthcare data management, AI-powered intelligence, and embedded action can accelerate measurable outcomes. About MedeAnalytics MedeAnalytics is the Enterprise Healthcare Performance company that delivers AI-driven, cloud-native solutions to help payers, providers, and employers measurably improve performance by reducing costs, improving MLR, increasing reimbursement, and elevating care quality. Its enterprise health data management platform - built on its proprietary Health Fabric(TM)- unifies clinical, claims, financial, and social data into a single, scalable source of truth that fuels insights, action, and AI. As the industry's healthcare intelligence partner of choice for more than 30 years, MedeAnalytics combines its platform, comprehensive analytics, AI-powered workflows, and Strategic Advisory(TM) services to transform intelligence into accountable execution - delivering greater ROI across value-based care, risk and quality, utilization management, network optimization, population health, and revenue cycle operations. MedeAnalytics empowers organizations to move faster from insight to impact with confidence and measurable results.

MedeAnalytics, a healthcare data analytics software-as-a-service provider, has appointed David Figueredo as chief innovation officer. Figueredo brings over 20 years of experience in healthcare technology and operations. He joins from Experian, where he served as vice president of innovation, leading artificial intelligence and product development initiatives. Previously, Figueredo was chief operating officer at WaveHDC until its acquisition by Experian in 2023, and held leadership roles at Change Healthcare for 15 years. In his new role, Figueredo will focus on developing AI-driven workflows and data-powered solutions to improve operational efficiency and care outcomes. CEO Steve Grieco said Figueredo's expertise in combining healthcare knowledge with AI strategies will help accelerate intelligent workflow development for clients across the healthcare ecosystem.